Prevalence of metabolic syndrome and its components in the menopausal transition: A systematic review;Prevalência de síndrome metabólica e seus componentes na transição menopáusica: Uma revisão sistemática

Cadernos de Saude Publica

Volumn 28, Issue 8, 2012, Pages 1423-1437

  Mendes, Karina Giane ^a,b   Theodoro, Heloísa ^c   Rodrigues, Alice Dalpicolli ^c   Olinto, Maria Teresa Anselmo ^c,d  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Menopause; Metabolic syndrome X; Post menopause; Premenopause

Indexed keywords

ABDOMINAL OBESITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MEDICAL RESEARCH; MENOPAUSE; METABOLIC SYNDROME X; PHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; STANDARD;

BIOMEDICAL RESEARCH; BLOOD GLUCOSE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; PREVALENCE; RISK FACTORS;

EID: 84865811076     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2012000800002     Document Type: Review

References (42)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
2. Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009; 60 Suppl 7:19-24.
3. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366:1059-62.
4. Reaven GM. The individual components of the metabolic syndrome: is there a raison d'etre? J Am Coll Nutr 2007; 26:191-5.
5. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33:351-75.
6. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004; 19:195-201.
7. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004; 33:328-36.
8. Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care 2007; 30:701-6.
9. World Health Organization. Research on the menopause in the 1990. Reports of a WHO scientific group. Geneva: World Health Organization; 1996.
10. Banks AD. Women and heart disease: missed opportunities. J Midwifery Womens Health 2008; 53:430-9.
11. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/ Progestin Intervention Trial. J Clin Endocrinol Metab 2003; 88:1646-52.
12. Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metabolism 2004; 53:507-12.
13. Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) 2010; 18:604-10.
14. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008; 168:1568-75.
15. Grundy SM. Multifactorial causation of obesity: implications for prevention. Am J Clin Nutr 1998; 67(3 Suppl):563S-72S.
16. Matsudo S, Matsudo V, Barros T. Impacto do envelhecimento nas variáveis antropométricas, neuromotoras e metabólicas da aptidão física. Rev Bras Ciênc Mov 2000; 8:21-32.
17. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61:344-9.
18. Coniglio RI, Nellem J, Gentili R, Sibechi N, Agusti E, Torres M. Metabolic syndrome in employees in Argentina. Medicina (B. Aires) 2009; 69:246-52.
19. Romaguera J, Ortiz AP, Roca FJ, Colon G, Suarez E. Factors associated with metabolic syndrome in a sample of women in Puerto Rico. Menopause 2010; 17:388-92.
20. Figueiredo Neto JA, Figueredo ED, Barbosa JB, Barbosa FF, Costa GR, Nina VJ, et al. Metabolic syndrome and menopause: cross-sectional study in gynecology clinic. Arq Bras Cardiol 2010; 95: 339-45.
21. Cho GJ, Park HT, Shin JH, Kim T, Hur JY, Kim YT, et al. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005. Menopause 2009; 16:998-1003.
22. Lin WY, Yang WS, Lee LT, Chen CY, Liu CS, Lin CC, et al. Insulin resistance, obesity, and metabolic syndrome among non-diabetic preand postmenopausal women in North Taiwan. Int J Obes (Lond) 2006; 30:912-7.
23. Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas 2007; 58:150-5.
24. Miller AM, Wilbur J, Chandler PJ, Sorokin O. Cardiovascular disease risk factors and menopausal status in midlife women from the former Soviet Union. Women Health 2003; 38:19-36.
25. Indhavivadhana S, Rattanachaiyanont M, Wongvananurak T, Kanboon M, Techatraisak K, Leerasiri P, et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric 2011; 14:58-65.
26. Mesch VR, Boero LE, Siseles NO, Royer M, Prada M, Sayegh F, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006; 9:40-8.
27. Rodrigues AD. Fatores associados à syndrome metabólica em mulheres no climatério em atendimento em ambulatório do sul do Brasil [Dissertação de Mestrado]. São Leopoldo: Programa de Pós-graduação em Saúde Coletiva, Universidade do Vale do Rio dos Sinos; 2011.
28. Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008; 196:590-7.
29. Nakazone MA, Pinheiro A, Braile MC, Pinhel MA, Sousa GF, Pinheiro Jr. S, et al. Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals. Rev Assoc Med Bras 2007; 53:407-13.
30. Santos AC, Ebrahim S, Barros H. Gender, socioeconomic status and metabolic syndrome in middleaged and old adults. BMC Public Health 2008; 8:62.
31. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008; 32:949-58.
32. Orsatti FL, Nahas EA, Nahas-Neto J, Maesta N, Padoani NP, Orsatti CL. Anthropometric measures: predictors of non-transmissible chronic diseases in postmenopausal women in the Southeast region of Brazil. Rev Bras Ginecol Obstet 2008; 30:182-9.
33. Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010; 65:262-6.
34. Ghosh A. Comparison of risk variables associated with the metabolic syndrome in preand postmenopausal Bengalee women. Cardiovasc J Afr 2008; 19:183-7.
35. Henneman P, Janssens AC, Zillikens MC, Frolich M, Frants RR, Oostra BA, et al. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome. J Intern Med 2010; 267:402-9.
36. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-13.
37. Sociedade Brasileira de Hipertensão; Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Nefrologia. V diretrizes brasileiras de hipertensão arterial. Arq Bras Cardiol 2007; 89:e24-e79.
38. Sieminska L, Wojciechowska C, Foltyn W, Kajdaniuk D, Kos-Kudla B, Marek B, et al. The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause. Endokrynol Pol 2006; 57:15-22.
39. Reaven G. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Clin Chem 2008; 54:785-7.
40. Sociedade Brasileira de Diabetes. Tratamento e acompanhamento do diabetes mellitus. Diretrizes da Sociedade Brasileira de Diabetes. Rio de Janeiro: Sociedade Brasileira de Diabetes; 2007.
41. Ferin M, Jewelewicz R, Warren M. The menstrual cycle: physiology, reproductive disorders and infertility. Oxford: Oxford University Press; 1993.
42. Lejskova M, Alusik S, Suchanek M, Zecova S, Pitha J. Menopause: clustering of metabolic syndrome components and population changes in insulin resistance. Climacteric 2011; 14:83-91.